FDA Import Refusal AEK-4819309-6/11/1 — AstraZeneca Pharma India Limited
The FDA refused shipment AEK-4819309-6/11/1 from AstraZeneca Pharma India Limited (India) on Mar 8, 2024. The refused product falls under Drugs and Biologics — GOSERELIN ACETATE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 8, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ICP81 GOSERELIN ACETATE (ANTI-NEOPLASTIC)
- Charges
- 75